Q Fever Igm Ifa Test

FDA 510(k) K922374 · Hillcrest Biologicals

Substantially Equivalent

510(k) numberK922374

Submission

Device name
Q Fever Igm Ifa Test
Applicant
Hillcrest Biologicals
Cypress, CA, US
Received
May 20, 1992
Decision date
October 21, 1992
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) statement available from FDA

Official FDA 510(k) record

Device classification

Product code
GPJ – Antiserum, Fluorescent, Q Fever
Device class
Class I (low risk)
Regulation
21 CFR 866.3500
Specialty
Microbiology

Other 510(k)s with product code GPJ

510(k)DeviceApplicantDecision
K913906Q Fever Igg Ifa TestGPJ · Traditional Hillcrest Biologicals10/21/1992SE

More from Hillcrest Biologicals

510(k)DeviceDecision
K913618Arbovirus Igm Ifa TestGQC · Traditional 12/03/1992SE
K913617Arbovirus Igg Ifa TestGQC · Traditional 12/03/1992SE
K913906Q Fever Igg Ifa TestGPJ · Traditional 10/21/1992SE
K900206Lyme Disease Igm ElisaLSR · Traditional 06/28/1991SE
K896594Ebv Vca Antibody (Igm)LJN · Traditional 01/16/1990SE
K884829Ebv Early Antigen (R+D)JRY · Traditional 04/12/1989SE
K883767Lyme Disease Ifa (Igm)LSR · Traditional 03/15/1989SE
K884591Ebv-Vca Antibody (Igg)GNP · Traditional 01/24/1989SE
K883487Lyme Disease Ifa (Igg)LSR · Traditional 12/13/1988SE
K875170Ebna AntibodyLLM · Traditional 05/23/1988SE

Questions and answers

When was Q Fever Igm Ifa Test cleared by the FDA?

Q Fever Igm Ifa Test (K922374) received a 510(k) decision of Substantially Equivalent on October 21, 1992, 154 days after the submission was received.

What is the product code of K922374?

The FDA product code is GPJ – Antiserum, Fluorescent, Q Fever, a Class I (low risk) device regulated under 21 CFR 866.3500.